Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
International Journal of Technology Assessment in Health Care
|
January 24, 2014
Comparative cost-effectiveness models for the treatment of multiple myeloma
Keith Cooper, Joanna Picot, Jackie Bryant, et al.
Journal of the American Society of Nephrology : JASN
|
October 25, 2001
Coexpressed nitric oxide synthase and apical beta(1) integrins influence tubule cell adhesion after cytokine-induced injury
Paul A Glynne, Joanna Picot, Thomas J Evans
Health Technology Assessment (Winchester, England)
|
May 3, 2016
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
Jonathan Shepherd, Keith Cooper, Petra Harris, et al.
The Cochrane Database of Systematic Reviews
|
April 17, 2009
Surgery for obesity
Jill L Colquitt, Joanna Picot, Emma Loveman, et al.
Pharmacoeconomics
|
December 13, 2005
Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease
Colin Green, Joanna Picot, Emma Loveman, et al.
The Journal of Biological Chemistry
|
June 25, 2002
Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output
Paul A Glynne, Katharine E A Darling, Joanna Picot, et al.
Obesity Surgery
|
August 29, 2012
Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation
Joanna Picot, Jeremy Jones, Jill L Colquitt, et al.
Pharmacoeconomics
|
October 18, 2018
Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Joanna Picot, Neelam Kalita, Wendy Gaisford, et al.
Drugs & Aging
|
April 13, 2006
A systematic review of the clinical and cost-effectiveness of memantine in patients with moderately severe to severe Alzheimer's disease
Joanna Kirby, Colin Green, Emma Loveman, et al.
Genetic Testing and Molecular Biomarkers
|
March 25, 2009
Psychosocial aspects of DNA testing for hereditary hemochromatosis in at-risk individuals: a systematic review
Joanna Picot, Jackie Bryant, Keith Cooper, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
International Journal of Technology Assessment in Health Care
|
January 24, 2014
Comparative cost-effectiveness models for the treatment of multiple myeloma
Keith Cooper, Joanna Picot, Jackie Bryant, et al.
Journal of the American Society of Nephrology : JASN
|
October 25, 2001
Coexpressed nitric oxide synthase and apical beta(1) integrins influence tubule cell adhesion after cytokine-induced injury
Paul A Glynne, Joanna Picot, Thomas J Evans
Health Technology Assessment (Winchester, England)
|
May 3, 2016
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
Jonathan Shepherd, Keith Cooper, Petra Harris, et al.
The Cochrane Database of Systematic Reviews
|
April 17, 2009
Surgery for obesity
Jill L Colquitt, Joanna Picot, Emma Loveman, et al.
Pharmacoeconomics
|
December 13, 2005
Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease
Colin Green, Joanna Picot, Emma Loveman, et al.
The Journal of Biological Chemistry
|
June 25, 2002
Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output
Paul A Glynne, Katharine E A Darling, Joanna Picot, et al.
Obesity Surgery
|
August 29, 2012
Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation
Joanna Picot, Jeremy Jones, Jill L Colquitt, et al.
Pharmacoeconomics
|
October 18, 2018
Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Joanna Picot, Neelam Kalita, Wendy Gaisford, et al.
Drugs & Aging
|
April 13, 2006
A systematic review of the clinical and cost-effectiveness of memantine in patients with moderately severe to severe Alzheimer's disease
Joanna Kirby, Colin Green, Emma Loveman, et al.
Genetic Testing and Molecular Biomarkers
|
March 25, 2009
Psychosocial aspects of DNA testing for hereditary hemochromatosis in at-risk individuals: a systematic review
Joanna Picot, Jackie Bryant, Keith Cooper, et al.
Page
of 2